Raising awareness of oesophageal cancer: The regional pilot Professor S. Michael Griffin Northern Oesophago-Gastric Cancer Unit Newcastle upon Tyne.

Slides:



Advertisements
Similar presentations
Seven Day Services Cost-Benefit Analysis - Approach and Key Issues David Halsall Clinical Quality and Efficiency Analytical Team 20 th January 2012.
Advertisements

Be Clear on Cancer Regional Oesophageal Cancer Awareness Campaign November 2013 Jo Preston Network Delivery Manager Northern Strategic Clinical Networks.
Shaping a blueprint for cancer Plymouth Cancer Summit Sean Duffy February 2015.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
Statistics on Obesity, PA & Diet: England, Jan 08 i Compiled by Sally Cornfield on behalf of PAN-WM Headline Findings.
National Oesophago–Gastric Cancer Audit Comparing local and national figures.
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
Nicola Barnstaple Programme Manager. Key challenges in Scotland Increasing cancer incidence – predicted 35,000 cases per year in 2020 Ageing population.
Awareness Campaigns for Oesophageal & Gastric Cancer D. Perren, J. Shenfine, S. M. Griffin Northern Oesophago-Gastric Cancer Unit Newcastle upon Tyne.
South West Public Health Observatory Part of the South West Observatory, a wider regional intelligence function Education and Health Dr Julia Verne Director.
Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.
Supporting Cancer Survivors - A New Aftercare System
Lung Cancer. Lung Cancer Incidence 1950s Male/Female ratio 6:1, this is now 7:5. (decreasing male smoking rates, increasing female smoking rates). Approximately.
An Initial Evaluation of the NAEDI Regional Awareness Pilots NB. SLIDES CONTAIN UNVALIDATED DATA NOT YET IN PUBLIC DOMAIN SO MUST NOT BE QUOTED OR PUBLISHED.
Early Diagnosis of Cancer Working with GP Practices in Islington.
Quit with Us: A social marketing intervention to motivate and assist individuals to stop smoking using Tenovus retail outlets. Maura Matthews and Dr Sioned.
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Quick Questions 1. 1.List statistics that highlight Glasgow’s special health problems. 2.Explain why it is important not to stereotype all people who live.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
SECTION B: SOCIAL ISSUES IN THE UK Study Theme 2: Wealth and Health in the UK 5.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
European Society of Cardiology Cardiovascular diseases in women.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Liverpool Community Alcohol Services 0151 – 259 –
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
Socio-economic inequalities in the pathway of care for pancreatic cancer James Brown, Jean Adams, Martin White & Mark Pearce Institute of Health & Society.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
The Effect of Obesity on the Radicality of Subtotal Oesophagectomy for Oesophageal Adenocarcinoma S Wahed, HV Jones, A Krishnan, J Shenfine, SM Griffin.
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
Dr Heather O Dickinson Department of Child Health University of Newcastle
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
Northern Region Colorectal Liver Metastases Study Guru Raghavendra.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Welcome Ian Carpenter Assistant Director, Communications & Engagement NHS Doncaster.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Making Every Contact Count (MECC) and Optimising Outcomes Dr Siân Griffiths Consultant in Public Health Medicine.
Adult Social Care and Health Select Committee Cancer in Nottingham Julie O’Boyle Specialty Registrar Public Health NHS Nottingham City Dr Chris Packham.
Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.
East Midlands Strategic Clinical Networks & Senate Cancer Roadshow.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
Primary Care Role in Cancer Screening & Inequalities Dr Lorna Porteous, GP Lead for Cancer, NHS Lothian March 14th 2017.
Oesophago–Gastric Cancer Audit
Upper Gastrointestinal Cancers Top ⑩ Tips
Oesophago–Gastric Cancer
National Oesophago–Gastric Cancer Audit 2015.
Lung cancer prevalence on the rise (Nov. 2014)
A Few Facts About Breast Cancer
The Ambition: Achieving 25% 5 Year Survival By 2025
Jane E Scullion Respiratory Nurse Consultant
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Oesophago–Gastric Cancer
Oesophago–Gastric Cancer Audit
Dr James Carlton, Medical Adviser
HEALTH PROFESSIONAL ENGAGEMENT PROGRAMME:
BOWEL CANCER SCREENING 11/7/18
Lung Cancer in Lewisham
Local Tobacco Control Profiles The webinar will start at 1pm
National Cancer Diagnosis Audit
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Cervical Cancer Surveillance, Screening, and Treatment
Oesophago-Gastric Cancer &
Presentation transcript:

Raising awareness of oesophageal cancer: The regional pilot Professor S. Michael Griffin Northern Oesophago-Gastric Cancer Unit Newcastle upon Tyne

Colorectal adenocarcinoma Small cell lung cancer Stage 1 Stage 3 Stage 1 Stage 3 Stage 1 Stage 3 Oesophageal adenocarcinoma Cancer (2010). Cancer of the esophagus and esophagogastric junction. Rice et al

How to improve outcomes?  Prevention  Earlier diagnosis  Centralisation of services  Patient selection/fitness  Surgical technique  Oncology  Critical care  Enhanced recovery

OESOPHAGO-GASTRIC (O-G) CANCERS  Around 12,900 people in England are diagnosed with O-G cancers each year. This equates to 35 people per day being diagnosed with these types of cancer  People over 50 make up 95% of all diagnoses  Over ¼ of all O-G cases present as an emergency  In England, approximately 10,200 people die from O-G cancers each year  If these cancers are diagnosed at the earliest stage, one-year relative survival is as high as 75-87%. At a late stage, it drops to just 20-21%.  More men than women are diagnosed with these cancers, and die from the disease Incidence data supplied by West Midlands KIT based on NCRS data. Deaths data supplied by West Midlands KIT based on ONS data

OESOPHAGEAL ADENOCARCINOMA  Fastest increasing solid cancer in Western World 1  UK has highest incidence rate in Men in the World 2  NorthEast England and West Scotland highest incidence in the UK  Directly related to Obesity and Reflux  Proven evidence that earlier diagnosis dramatically improves cure rates to above 90%  Early diagnosis of precancerous changes (Barretts Oesophagus) can prevent disease 1 Dan Med J (2012). Barrett’s esophagus. Diagnosis, follow-up and treatment. Bremholm L et. al 2 Oesophagus (2014). Global incidence of oesophageal cancer by histological subtype in Arnold M et. al

“OESOPHAGOOSE”– born 2008

Oesophagoose - evaluation 1850 people questioned in street intercept surveys 39% had seen campaign material

Local Be Clear on Cancer pilots  Seven local pilots across England 1  Data from one pilot shows that during the campaign there was a 17% statistically significant increase in GP visits in the over 55s compared with the same period in Pilot scheme areasControl areas Upper GI 2 week wait referrals ↑ 26% ↑ 16% 2 week wait oesophageal cancer diagnosis ↑ 20%↑ 3% 1 Be Clear on Cancer (2014). Evaluation summary. Available from 2 Source: Mayden (IT healthcare specialist company)

Preparation for the regional Be Clear on Cancer Pilot, Feb10-March  Which symptoms to target? n=788 Heartburn/Indigestion (No dysphagia) Dysphagiap (Chi 2 ) N0N0 21 (28.4%)39 (7.7%)< Stage (37.8%)54 (10.7%)< M+10 (13.6%)120 (23.8%) Curative Intent53 (71.6%)248 (49%) A national panel of experts, including clinicians and patient group representatives, reviewed the data and evidence to decide which symptoms to lead with. Data provided by NOGU with a diagnosis of oesophageal cancer since January 2008

Regional pilot February 10-March Northeast and Cumbria  Bus stop billboards  Newspaper coverage  Postal mailshot  TV advert

Regional Be Clear on Cancer pilot – evaluation 2014  87% exposure within the target audience  13% awareness of advertising about heartburn  31% recall of heartburn in the pilot region when asked about advertising on certain symptoms  Increase in prompted knowledge of heartburn as a definite warning sign of OG cancer  11% pre-campaign vs 31% post-campaign Data source: TNS-BMRB (a market research agency) Data source: TNS-BMRB

Impact on services follow the regional Be Clear on Cancer pilot 2WW: Eight trusts in the regional pilot saw an increase in 2WW referrals over the campaign period, particularly in March 2014 Max average 15 extra 2WW referrals per week per trust. This reduced in April 2014 to on average 7 extra 2WW per week per trust A reduction in the percentage of people seen within the 14 day window also decreased over this time, from 94% in Feb 2014, to 90% in May 2014, with some recovery seen by July 2014 (92%) No additional increase in 2WW referrals was observed in the trusts not covered by the pilot, although a slight decrease in the percentage of people seen within the 14 day window was observed (from a peak of 95% in Feb 2014, to a low of 92% in Jun 2014) Data provided by Department of Health

Impact on services following the regional Be Clear on Cancer pilot Endoscopy: The average increase per week was 16 additional gastroscopies over the course of the pilot (data used from Mar 2014 to Jul 2014) However the range across eight NHS trusts in the pilot areas went from 1 additional gastroscopy per week up to 23 additional gastroscopies Caveat… The region for the pilot has abnormally high activity at baseline levels compared to the rest of the country, even outside the campaign period Average waiting times in the pilot sites showed an increase from Feb 2014 to May 2014, with a slight decrease between Jun Aug 2014 Neither of these trends were observed in the trusts outside of the pilot. Data provided by Department of Health

Things to consider…  High risk patients: Deprivation: Incidence is higher in more socioeconomically deprived areas for both oesophageal and stomach cancers Smoking is the biggest lifestyle risk for oesophageal cancer, accounting for nearly 7 out of 10 cases. It accounts for nearly 1 out of 5 cases of stomach cancer Diet: Approximately 1 in 2 cases of oesophageal and 1 in 3 cases of stomach cancer are linked with consuming too little fruit and vegetables over a long time  The number of prescriptions for PPIs was around 50m in England for the financial year 2013/14  Women are 50% more likely than men to have seen their GP at least 3 times before a referral is made for a suspected oesophageal cancer Data provided by NCIN from a range of sources, details can be provided

Epidemiological study showing increased 2ww referral patterns on resectability rates  Appropriate, informed increase in 2ww referrals would be expected to improve the rate of resectability Gut (2014). Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: Retrospective analysis of Hospital Episode Statistics. Shawihdi et al

Towards improved awareness and early treatment

Summary  Upper GI cancer awareness campaigns can lead to  Improved disease awareness and understanding  Manageable increase in referrals  Increased rates of cancer diagnosis  Longer term evaluation awaited